Pharmacogenomics Market Evolving Technology, Size, Share, Emerging Trends and Key Players Outlook to 2023 | by Assurex Health Inc., Pathway Genomics, Teva Pharmaceutical Industries Ltd., Myriad Genetics, GeneDx., etc
Pharmacogenomics Market Research Report, By Technology (Microarray, Sequencing, Polymerase Chain Reaction) By Application (Cardiology, Neurological Disorders) By End Users (Hospitals, Research Organizations, Academic Institute) - Global Forecast till 2023
Market Drivers and Top Barriers
The deciding factors in the pharmacogenomics market growth include the surging expenditure in research and development (R&D) along with the elevating rate of adverse reactions. World over, there has been a rising focus on precision medicine coupled with the growing need for drug safety as well as efficacy, which has led to the market expansion in recent years.
On that note, the strong focus on precision medicine is striving to expand the pharmacogenomics market, as the primary aim of precision medicine is integrating genetic as well as environmental information of certain diseases along with their responses to specific treatments. This factor helps in targeted drug therapies, in addition to the growing adoption of treatment procedures that reduce the side effects and achieve accurate results, which makes extensive use of pharmacogenomics. For instance, in 2015, the United States (U.S.) government had implemented a new precision medicine initiative to augment the development of individualized care, which includes genetic variability for a variety of chronic disorders.
Get Free PDF Sample Copy of Report @ https://www.marketresearchfuture.com/sample_request/1177
Additionally, the rapid growth in the number of research studies associated with sequencing, particularly next-generation sequencing, will raise the demand for pharmacogenomic tests in the years to come. This factor will play an integral role in market growth to a large extent.
Pharmacogenomics is considered to be a vital aspect in terms of cancer treatment, having proved to be a favorable option helping with the survival of patients. Over and above that, pharmacogenomics also has managed to reduce the additional cost owing to unresponsive treatment. Therefore, growing use of pharmacogenomics for the treatment of cancer has resulted in numerous significant discoveries, which is bound to contribute to the growth of the worldwide market in the upcoming period.
Global Pharmacogenomics Market: Competitive Analysis
Assurex Health Inc. (U.S.), Pathway Genomics (U.S.), Teva Pharmaceutical Industries Ltd. (Israel), Myriad Genetics, Inc. (U.S.), GeneDx. (U.S.), Future Science Group (U.S.), GeneTech (U.S.), 23andMe, Inc. (U.S.), and others.
Latest Industry Updates
May 2019: Premier Health Group has partnered with Navigator Genomics (NGT), in a bid to offer access to their Pharmacogenomic Testing. This testing will be for medical cannabis along with 416 of the popular medicines. This will ensure that the patients are provided with the best medical drugs, avoiding the medication that are not effective.
October 31, 2018: The U.S. Food and Drug Administration has recently announced that they have approved the marketing of 23andMe’s reports on pharmacogenetics. The genetic-testing company claims are designed to assess whether the genetics will affect an individual’s ability to metabolize certain drugs which include antidepressants.
Nov 2017: Myriad Genetics, Inc., announced positive results from a double-blind, multi-center, randomized controlled trial assessing the impact of the GeneSight Psychotropic test (GeneSight) on psychiatric treatment response in 1,200 patients with major depressive disorder. GeneSight is one of the leading pharmacogenomics test to help guide medication selection for mental health disorders.
Global Pharmacogenomics Market: Segmental Analysis
The global market for pharmacogenomics has been segmented on the basis of technology, application, and end user.
The types of technology in the market include microarray, sequencing, polymerase chain reaction, and others. The sequencing segment is further segmented on the basis of Sanger sequencing, pyrosequencing, next-generation sequencing, and others.
The segments based on application are oncology, cardiology, neurological disorders, and others. The oncology segment can be considered for breast cancer, lung cancer, and others.
On the basis of end users, the market is segmented into hospitals, research organizations, academic institute, and others.
Global Pharmacogenomics Market: Regional Analysis
The pharmacogenomics market is spread across the primary regions of the Americas, Europe, Asia Pacific, and the Middle East and Africa.
The Americas has been identified as the dominant region in the global pharmacogenomics market, on account of highly-developed healthcare industry coupled with the inclusion of developed countries such as the United States (U.S.) as well as Canada. Furthermore, the expansion of the patient pool suffering from cardiovascular diseases as well as the growing healthcare expenditure is nurturing the growth of the regional market. As per the Centers for Diseases Control and Prevention, in 2015, heart disease had been the main cause of death for men as well as women in the U.S. In addition, the analysis suggested that the spending on healthcare for heart diseases in the country touches the valuation of USD 200 billion every year.
Data analysts concur that Europe stands second in the global pharmacogenomics market, with the Asia Pacific following suit. The surge in the funds for research and development on top of the increasing government support and the expanding patient population will prove to be instrumental in the market growth. Plus, the region also benefits from the primary contribution of the developed nations such as France and Germany with excellent growth prospects in the medical field.
Racing ahead at the fastest growth rate is the region of Asia Pacific, with the primary reasons being the burgeoning patient pool and the progressively growing economies such as India and China in the region. The Indian Brand Equity Foundation had reported in 2016 that the biotech industry in India is expected to arrive at the valuation of USD 100 billion by the year 2025, crossing the value of USD 7 billion it had reached in 2015. The industry is also expected to expand at a growth rate of 30.46% in the mentioned evaluation period, as per reports.
Meanwhile, the growth of the Middle East & Africa market has been inferior to other regions in the global pharmacogenomics market. This stunted growth can be the result of the poor economy, low expenditure on healthcare, and the rigid government policies, particularly in Africa. Concurrently, the substantial portion of the regional market is controlled by the Middle East, with the backing from the well-established healthcare industry combined with the growing healthcare expenditure. Apart from this, developed countries such as Dubai, Saudi Arabia, and Qatar have a big hand in the growth of the Middle East & Africa market.
Browse Complete Report @ https://www.marketresearchfuture.com/reports/pharmacogenomics-market-1177
Market Research Future
Hadapsar, Pune – 411028
Phone: +1 646 845 9312
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Statistical Report, Continuous-Feed Research (CFR), and Market Research & Consulting Services.
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Pharmacogenomics Market Evolving Technology, Size, Share, Emerging Trends and Key Players Outlook to 2023 | by Assurex Health Inc., Pathway Genomics, Teva Pharmaceutical Industries Ltd., Myriad Genetics, GeneDx., etc here
News-ID: 1814490 • Views: 991
More Releases from Market Research Future
Field Programmable Gate Array Market 2021 Size, Share, Industry Analysis, Emergi …
Field Programmable Gate Array Market by technology (EEPROM, Antifuse, SRAM, Flash, and others (EPROM and PROM), by Application (data processing, consumer electronics, industrial, military & aerospace, automotive, telecom, and others), and by Type (high-end, mid-end, and low-end FPGA) - Global Opportunity Analysis and Industry Forecast, 2017-2023 According to a recent report published by Allied Market Research, titled, Field Programmable Gate Array Market by Technology, Application, and Type: Global Opportunity Analysis and
Semiconductor IC Tester Market Growth Factor, Demand, Size, Share, Trends, Growt …
The Semiconductor IC Tester Market research report includes Market segmentation and overlays shadow upon the leading market players highlighting the favourable competitive landscape and trends prevailing over the years. This study provides information about the sales and revenue during the historic and forecasted period of 2019 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the Semiconductor IC Tester market growth. Semiconductor IC Tester is
Tilt Sensor Market Share, COVID-19 Pandemic Impact, Comprehensive Analysis, Oppo …
Global Tilt Sensor Market Highlights: The global Tilt Sensor Market is growing rapidly over 7.42% of CAGR and is expected to reach at USD 257.64 million by the end of forecast period. The global tilt sensor market has been witnessing a steady growth over the last few years on account of rapid growth of automobile and transportation market, high implementation of sensors in the constructions machines and rising demand for tilt
High Altitude Long Endurance Market Demand, Growth, COVID-19 Pandemic Impact, Ap …
High Altitude Long Endurance (Pseudo Satellite) Market Overview Market Research Future (MRFR) anticipates that the High Altitude Long Endurance Market 2020 could potentially achieve a strong valuation of USD 23 billion by 2022. The market is also projected to advance at an approximate rate of 9% between 2016 and 2022 (review period). We will provide covid-19 impact analysis with the report. The research on COVID-19 impact offers an in-depth analysis post
More Releases for Pharmacogenomic
Pharmacogenomic (PGx) Testing Market Globally Expected to Drive Growth through 2 …
Pharmacogenomic (PGx) testing is study of the effect of individual genetic make-up on the therapeutic effect of the medication. The individual response to the medication is determined by the various factor such as weight, age, diet, habits, and genetic factors, etc. The genetic make-up of the individual majorly decides the metabolism rate of the medication along with other factors. Depending on the variation in person to person gene make-up, metabolism of
Genetic testing market size is expected to reach $21 billion by 2027, registerin …
According to a new report published by Report Ocean, titled, "Genetic testing market by Type, Technology, and Application: Opportunity Analysis and Industry Forecast, 2019–2027," the global genetic testing market was valued at $12 billion in 2019, and is expected to reach $21 billion by 2027, registering a CAGR of 10.1% from 2019 to 2027. GET SAMPLE PAGES @ https://www.reportocean.com/industry-verticals/sample-request?report_id=AMR1256 Genetic testing is the study of genes that analyze genetic material in
Genetic testing market Expected to Reach $21 Billion by 2027
According to a new report published by Allied Market Research, titled, "Genetic testing market by Type, Technology, and Application: Opportunity Analysis and Industry Forecast, 2019–2027," the global genetic testing market was valued at $12 billion in 2019, and is expected to reach $21 billion by 2027, registering a CAGR of 10.1% from 2019 to 2027. know more: https://www.alliedmarketresearch.com/genetic-testing-market Genetic testing is the study of genes that analyze genetic material in
Pharmacogenomic (PGx) Testing Market Size Projected to Rise Lucratively during 2 …
Pharmacogenomic (PGx) testing is study of the effect of individual genetic make-up on the therapeutic effect of the medication. The individual response to the medication is determined by the various factor such as weight, age, diet, habits, and genetic factors, etc. The genetic make-up of the individual majorly decides the metabolism rate of the medication along with other factors. Depending on the variation in person to person gene make-up, metabolism
Pharmacogenomic (PGx) Testing Market Exhibits Higher Growth Prospects during 201 …
Increasing use of the patient specific treatment expected to drive the growth of the pharmacogenomic (PGx) testing market. The increasing emphasis of healthcare professionals to minimize sever adverse reactions of medication which varies person to person tremendously further expected to drive the growth of the Pharmacogenomic (PGx) Testing Market. The growing patient specific approach for the treatment of chronic diseases and study of factors which can impact treatment such as
Genetic Testing Global Market Application – predictive and diagnostic testing, …
Global Genetic Testing Market WiseGuyRerports.com Presents “Global Genetic Testing Market 2018-2022” New Document to its Studies Database. The Report Contain 140 Pages With Detailed Analysis. Description This industry research report presents a detailed analysis of the genetic testing market by product type (analyzers and consumables) and by application (predictive and diagnostic testing, prenatal, newborn, and pre-implantation testing, pharmacogenomic testing, and forensic, relationship, and ancestry testing). This report also presents an analysis based on